CRSP

CRISPR Therapeutics AG

Healthcare›Biotechnology|NASDAQ Global Market|CH

Price

$49.51

Market Cap

$4.75B

Beta

1.79

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-92.73%

EPS Growth (YoY)-49.20%

Revenue CAGR 3Y+81.76%

P/E Ratio0.0

PEG Ratio—

FCF Yield-7.28%

Debt / Equity0.21

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for CRSP.